JUL 12 2026
EMD Serono — pimicotinib
for tenosynovial giant cell tumor
for tenosynovial giant cell tumor
Tenosynovial giant cell tumor is a rare, typically benign growth that forms in the joints and soft tissues, often causing pain, swelling, and limited mobility. Pimicotinib is a drug that targets specific cellular pathways involved in the abnormal growth of these tumors. By blocking these pathways, pimicotinib may help reduce tumor size and alleviate symptoms, potentially improving joint function for patients.
The goal of this clinical trial is to assess the efficacy and safety of Pimicotinib (ABSK021) in patients with Tenosynovial Giant Cell Tumor (TGCT). The main questions it aims to answer are: * Whether the Pimicotinib(ABSK021) works well in patients with TGCT
Source: ClinicalTrials.gov